Globus Medical to Exhibit Latest Advancements in MIS Spine Surgery at SMISS Annual Forum

Audubon, Pennsylvania, UNITED STATES

AUDUBON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and navigation system along with its latest advancements in expandable interbody technology at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum being held September 6-8, 2018, in Las Vegas, Nevada.

As part of the Forum’s scientific agenda, two clinical studies will be presented highlighting Globus Medical’s expandable lateral interbody spacer technology designed to restore disc height, increase lordosis, and reduce subsidence compared to traditional static spacers. The company will also host an ExcelsiusGPS® workshop presented by Dr. Sabino D’Agostino, a neurosurgeon from South Carolina, who will discuss his transition to the ExcelsiusGPS® platform and the impact it has had on his minimally invasive spine surgery procedures. 

“As leaders in the musculoskeletal device industry, we are committed to supporting research, education, and development of medical advancements through minimally invasive spine surgery,” said Andrew Iott, Senior Vice President, Global Product Development. “We are proud to be a sponsor of SMISS and are excited to showcase our state-of-the-art ExcelsiusGPS® robotic system and best-in-class platform of innovative expandable implants for MIS spine surgery.”

Globus welcomes SMISS attendees to clinical presentations and workshops on Friday, September 7.

7:30am: Pompeian III/IV
ExcelsiusGPS® First Clinical Experience
Sabino D’Agostino, MD; Charleston Brain and Spine, Charleston, SC

11:05am: Florentine Ballroom
A Clinical Study to Evaluate Static versus Expandable Lateral Lumbar Interbody Fusion Devices: With One-year Follow-up
Richard Frisch, MD; Southeastern Spine Institute, Mount Pleasant, SC

11:17am: Florentine Ballroom
Do Expandable Cages Lead to a Higher Incidence of Subsidence? Two-year Follow-up of Lateral Lumbar Interbody Fusions
Dan Cohen, MD; Spine Care Institute of Miami Beach, Miami Beach, FL

Globus Medical invites meeting attendees to Booth# 201 to experience its most recent product innovations and discuss MIS advancements.

About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at

Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.

Brian Kearns
Vice President, Business Development and Investor Relations
Phone: (610) 930-1800